News | June 24, 2011

American Heart Association CEO Praises Graphic Tobacco Warning Labels


June 24, 2011 — American Heart Association (AHA) CEO Nancy Brown praised the new, larger tobacco packaging warning labels unveiled this week by the U.S. Food and Drug Administration (FDA). The labels include graphic images of disease caused by tobacco.

“New cigarette warning labels unveiled today by the Food and Drug Administration will help give us the momentum needed to eradicate tobacco use in our nation,” Brown said. “For the first time in 25 years, cigarette warning labels have been dramatically altered to graphically demonstrate the specific, serious health risks associated with smoking, and these warnings will not only tell smokers how bad tobacco use is, but also direct them to smoking cessation resources that can help them quit.”

According to the Centers for Disease Control and Prevention, more than 45 million Americans smoke cigarettes - about 20 percent of the population - and one in five high school students still smoke. The new health warnings represent an aggressive approach to reducing smoking rates that have leveled off in recent years as tobacco companies continue to launch campaigns to entice new smokers and maintain current customers.

“The American Heart Association strongly believes that the graphic depictions of smoking-related diseases on cigarette packages will drive home the message that tobacco use is an equal opportunity killer, affecting smokers and nonsmokers alike,” Brown said. “In the U.S., about one-third of smoking-related deaths are linked to heart disease and stroke. Cigarette smoking causes about 443,000 premature deaths each year and about 49,000 of these deaths are due to second-hand smoke. Undoubtedly, the new graphic health warnings will heighten awareness about the dangers of smoking and, more importantly, encourage smokers to quit and discourage smoking initiation. We're confident that the new labels will move us closer to our goal of making the nation 100 percent smoke-free.”

For more information: www.heart.org



Related Content

News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
Subscribe Now